Canada: NACI recommends that AstraZeneca coronavirus vaccine should not be used in adults under 55 years of age

NACI recommends that AstraZeneca COVID-19 vaccine should not be used in adults under 55 years of age at this time while the safety signal of Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT) following vaccination with AstraZeneca COVID-19 vaccine is investigated further.  More...

Norway blood clots: “The Norwegian Medicines Agency believes that there is a probable connection with the AstraZeneca vaccine and these rare cases”

The Norwegian Institute of Public Health has paused vaccination with COVID-19 Vaccine AstraZeneca after we became aware of cases of serious suspected side effects with the combination of blood clots, bleeding and low platelet counts.  More...